FMS News and Press, Fresenius Medical Care AG From 10/30/20

Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2020 Earnings Conference Call October 29, 2020, 10:30 ET Company Participants Dominik Heger - EVP & Head, IR, Strategic Development & Communications Robert Powell - Chairman & CEO Helen Giza - CFO Conference Call Participants Patri...

Image source: The Motley Fool. Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) Q3 2020 Earnings Call Oct 29, 2020 , 9:30 a.m. ET Operator Continue reading For further details see: Fresenius Medical Care AG & Co. KGaA (FMS) Q3 202...

Fresenius delivered very solid results despite the pandemic. Importantly, all guidance was confirmed. Given the demonstrated resilience of the company, it looks substantially undervalued. For further details see: Fresenius Q3 2020 In-Depth Review

The following slide deck was published by Fresenius Medical Care AG & Co. KGaA in conjunction with their 2020 Q3 earnings call. For further details see: Fresenius Medical Care AG & Co. KGaA 2020 Q3 - Results - Earnings Call Presentation

Fresenius Medical Care (FMS): Q3 GAAP EPS of €1.21 beats by €0.06.Revenue of €4.41B (-0.2% Y/Y) misses by €10M.Press Release For further details see: Fresenius Medical Care EPS beats by €0.06, misses on revenue

Following several pre-COVID guidance cuts, Fresenius had lost investors' faith. The pandemic, while certainly not a positive for a hospital operator, has not produced any fundamental deterioration of the business. COVID-19 has also masked an underlying improvement of Fresenius' He...

Fresenius Medical Care outlined its guidance for the next five years. Not much will change, except a greater focus on integrated and value-based care. We will see what this implies. Other interesting initiatives won't move the needle for the time being. For further details s...

The earnings season came to a close and markets were mostly flat. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks. Whether it is a bubble or not, I won't stop investing. My dividend income from 37 corporations amounted...

The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Vifor Fresenius Medical Care Renal Pharma's Velphoro (mixture of polynuclear iron (III)-oxyhydroxide, sucrose and starches) for the control of serum phosphorus levels in pediatric pa...

Quick Take Outset Medical ( OM ) has filed to raise $175 million from the sale of its common stock in an IPO, according to an amended registration statement . The company has developed an improved kidney dialysis device for institutional and home use. OM is growing quickly from a low ba...